Loading financial statements…
Import this data to Google Sheets with:
=jivedata("DAKT","financials")Full statements spill as a table. For one cell: =jivedata("DAKT","Revenue") or =jivedata("DAKT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
DAKT • CIK 0000915779
| (in thousands, except per share data) | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $818,083 | $756,477 | $838,706 | $854,299 |
| Cost of Revenue | $595,640 | $560,990 | $609,700 | $618,766 |
| Gross Profit | $222,443 | $195,487 | $229,006 | $235,533 |
| Operating Income (Loss) | $87,115 | $33,118 | $60,848 | $62,512 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $54,051 | $-5,851 | $58,334 | $61,778 |
| Income Tax Expense (Benefit) | $19,430 | $4,270 | $12,958 | $13,442 |
| Net Income (Loss) Attributable to Parent | $34,621 | $-10,121 | $45,376 | $48,336 |
| Selling Expense | $56,954 | $60,011 | $64,815 | $66,971 |
| General and Administrative Expense | $42,632 | $63,498 | $59,885 | $61,149 |
| Research and Development Expense | $35,742 | $38,860 | $43,458 | $44,901 |
| Operating Expenses | $135,328 | $162,369 | $168,158 | $173,021 |
| Investment Income, Net | $-3,418 | $1,347 | $3,630 | $3,871 |
| Other Nonoperating Income (Expense) | $-13,096 | $-17,795 | $-6,144 | $-4,605 |
| Weighted Average Number of Shares Outstanding, Basic | 45,901,000 | 47,587,000 | 48,564,000 | 47,847,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 46,543,000 | 47,587,000 | 49,382,000 | 48,547,000 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 642,000 | 0 | 818,000 | 700,000 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $81,299 | $127,507 | $131,639 | $154,585 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $117,186 | $92,762 | $118,590 | $154,700 |
| Property, Plant and Equipment, Net | $71,752 | $73,884 | $64,263 | $64,292 |
| Inventory, Net | $138,008 | $105,839 | $110,471 | $117,517 |
| Financing Receivable, after Allowance for Credit Loss, Noncurrent | $562 | $1,030 | $1,125 | $371 |
| Contract with Customer, Asset, after Allowance for Credit Loss, Current | $55,800 | $41,169 | $66,552 | $51,608 |
| Goodwill | $3,226 | $3,188 | $3,685 | $3,605 |
| Financing Receivable, after Allowance for Credit Loss, Current | $298 | $2,437 | $3,405 | $3,499 |
| Finite-Lived Intangible Assets, Net | $840 | $568 | $3,263 | $3,190 |
| Prepaid Expense and Other Assets, Current | $8,531 | $8,520 | $11,278 | $15,747 |
| Debt Issuance Costs, Gross | $2,530 | $1,289 | $0 | $0 |
| Income Taxes Receivable, Current | $448 | $3,217 | $6,047 | $3,120 |
| Investments and Other Noncurrent Assets | $21,163 | $9,378 | $11,828 | $12,906 |
| Assets, Current | $401,949 | $381,451 | $447,982 | $500,776 |
| Deferred Income Tax Assets, Net | $25,862 | $32,104 | $22,266 | $22,240 |
| Assets | $527,884 | $502,892 | $554,412 | $607,380 |
| Product Warranty Accrual, Noncurrent | $21,388 | $23,124 | $24,362 | $24,663 |
| Contract with Customer, Liability, Noncurrent | $16,342 | $18,421 | $20,655 | $20,301 |
| Other Liabilities, Noncurrent | $5,759 | $6,839 | $5,289 | $4,633 |
| Long-term Line of Credit, Noncurrent | $53,164 | $10,487 | $9,629 | $9,355 |
| Deferred Income Tax Liabilities, Net | $143 | $85 | $22 | $22 |
| Liabilities, Noncurrent | $96,796 | $58,956 | $59,957 | $58,974 |
| Long-term Debt, Current Maturities | $1,500 | $1,500 | $1,150 | $1,150 |
| Accounts Payable, Current | $60,757 | $46,669 | $68,617 | $80,319 |
| Contract with Customer, Liability, Current | $65,524 | $69,050 | $65,310 | $85,969 |
| Accrued Liabilities, Current | $43,028 | $41,705 | $44,858 | $49,865 |
| Product Warranty Accrual, Current | $16,540 | $12,706 | $12,398 | $13,159 |
| Accrued Income Taxes, Current | $4,947 | $375 | $1,375 | $316 |
| Liabilities, Current | $192,296 | $172,005 | $193,708 | $230,778 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $65,525 | $0 | $0 | $0 |
| Additional Paid in Capital | $52,046 | $189,940 | $196,837 | $198,895 |
| Retained Earnings (Accumulated Deficit) | $138,031 | $127,910 | $173,286 | $192,716 |
| Treasury Stock, Value | $10,285 | $39,759 | $65,324 | $69,734 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-6,525 | $-6,160 | $-4,052 | $-4,249 |
| Stockholders' Equity Attributable to Parent | $238,792 | $271,931 | $300,747 | $317,628 |
| Preferred Stock, Shares Authorized | 50,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares Authorized | 115,000,000 | 115,000,000 | 115,000,000 | 115,000,000 |
| Common Stock, Shares, Issued | 48,121,000 | 53,030,000 | 53,650,000 | 53,715,000 |
| Treasury Stock, Common, Shares | 1,907,000 | 3,979,000 | 5,406,000 | 5,631,000 |
| (in thousands, except per share data) | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $34,621 | $-10,121 | $45,376 | $48,336 |
| Net Cash Provided by (Used in) Operating Activities | $63,241 | $97,713 | $49,217 | $54,553 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-69 | $-653 | $794 | $716 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $56,988 | $45,829 | $4,132 | $17,729 |
| Depreciation, Amortization and Accretion, Net | $19,291 | $19,547 | $19,339 | $19,217 |
| Payments to Acquire Property, Plant, and Equipment | $16,980 | $19,494 | $14,917 | $14,754 |
| Gain (Loss) on Disposition of Property Plant Equipment | $-44 | $156 | $209 | $199 |
| Proceeds from Sale of Property, Plant, and Equipment | $174 | $277 | $615 | $616 |
| Share-based Payment Arrangement, Noncash Expense | $2,090 | $2,944 | $4,905 | $5,168 |
| Cash Acquired from Acquisition | — | — | $44 | $44 |
| Income (Loss) from Equity Method Investments | $-3,764 | $-3,053 | $-2,008 | $-1,203 |
| Proceeds from Sale and Maturity of Marketable Securities | $550 | $0 | $0 | $0 |
| Financing Receivable, Credit Loss, Expense (Reversal) | — | $15,480 | $3,205 | $2,410 |
| Payments to Acquire Equity Method Investments | $5,050 | $4,565 | $5,383 | $3,836 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $373 | $-644 | $627 | $244 |
| Net Cash Provided by (Used in) Investing Activities | $-21,306 | $-23,782 | $-19,641 | $-17,930 |
| Deferred Income Tax Expense (Benefit) | $-9,069 | $-6,300 | $9,938 | $9,928 |
| Asset Impairment Charges | $6,359 | $0 | $0 | $0 |
| Write off of Deferred Debt Issuance Cost | $3,353 | $0 | $0 | $0 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $14,135 | $-51,389 | $35,972 | $31,754 |
| Proceeds from Notes Payable | $41,172 | $0 | $1,400 | $1,400 |
| Repayments of Notes Payable | $19,434 | $2,108 | $2,883 | $2,671 |
| Payments of Debt Issuance Costs | $7,205 | $0 | $0 | $0 |
| Repayments of Long-term Debt | $410 | $414 | $104 | $0 |
| Payments for Repurchase of Common Stock | $0 | $29,474 | $25,565 | $19,323 |
| Proceeds from Stock Options Exercised | $1,302 | $5,153 | $1,796 | $1,866 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $303 | $606 | $882 | $882 |
| Net Cash Provided by (Used in) Financing Activities | $15,122 | $-27,449 | $-26,238 | $-19,610 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $81,678 | $127,507 | $131,639 | $149,368 |